Ningbo Yaoshang Yanchuang Chenkai Venture Capital Partnership (Limited Partnership)
Beijing, Beijingyccapital.cn
Overview
A venture capital fund managed by Yanchuang Capital (源创资本). The fund was a cornerstone investor in the 2023 IPO of Laekna, a clinical-stage biotechnology company. The managing firm, Yanchuang Capital, focuses on private equity and venture capital investments in high-tech and emerging industries, including biotechnology/healthcare, semiconductors, and advanced manufacturing.
Portfolio Companies
2
Website
yccapital.cnInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Laekna, Inc. | Jun 2023 | IPO | Co-investor |
| Lai Kai Pharmaceutical Technology | Jun 2023 | IPO | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
